The<i>Staphylococcus aureus</i>Network Adaptive Platform Trial Protocol: New Tools for an Old FoeSteven Y. C. Tong, Adrian Dunlop, Nick Daneman et al.|Clinical Infectious Diseases|2022Cited by 98
A Randomized Trial of Nafamostat for Covid-19Susan C. Morpeth, Nigel Raymond, Balasubramanian Venkatesh et al.|NEJM Evidence|2023Cited by 14